1. Home
  2. AXGN vs TRIN Comparison

AXGN vs TRIN Comparison

Compare AXGN & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • TRIN
  • Stock Information
  • Founded
  • AXGN N/A
  • TRIN 2007
  • Country
  • AXGN United States
  • TRIN United States
  • Employees
  • AXGN N/A
  • TRIN N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TRIN Finance/Investors Services
  • Sector
  • AXGN Health Care
  • TRIN Finance
  • Exchange
  • AXGN Nasdaq
  • TRIN Nasdaq
  • Market Cap
  • AXGN 1.1B
  • TRIN 1.1B
  • IPO Year
  • AXGN N/A
  • TRIN 2021
  • Fundamental
  • Price
  • AXGN $27.08
  • TRIN $14.39
  • Analyst Decision
  • AXGN Strong Buy
  • TRIN Buy
  • Analyst Count
  • AXGN 7
  • TRIN 4
  • Target Price
  • AXGN $27.71
  • TRIN $15.63
  • AVG Volume (30 Days)
  • AXGN 921.9K
  • TRIN 834.8K
  • Earning Date
  • AXGN 10-29-2025
  • TRIN 11-05-2025
  • Dividend Yield
  • AXGN N/A
  • TRIN 14.23%
  • EPS Growth
  • AXGN N/A
  • TRIN 25.79
  • EPS
  • AXGN N/A
  • TRIN 2.17
  • Revenue
  • AXGN $214,709,000.00
  • TRIN $268,271,000.00
  • Revenue This Year
  • AXGN $21.57
  • TRIN $27.19
  • Revenue Next Year
  • AXGN $15.79
  • TRIN $8.97
  • P/E Ratio
  • AXGN N/A
  • TRIN $6.62
  • Revenue Growth
  • AXGN 18.72
  • TRIN 30.76
  • 52 Week Low
  • AXGN $9.22
  • TRIN $12.50
  • 52 Week High
  • AXGN $27.64
  • TRIN $16.82
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 80.52
  • TRIN 39.03
  • Support Level
  • AXGN $23.00
  • TRIN $14.33
  • Resistance Level
  • AXGN $24.92
  • TRIN $14.63
  • Average True Range (ATR)
  • AXGN 1.13
  • TRIN 0.27
  • MACD
  • AXGN 0.12
  • TRIN -0.03
  • Stochastic Oscillator
  • AXGN 86.79
  • TRIN 14.84

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

Share on Social Networks: